First Rate Lab LLC

First Rate Lab LLC was paid $951K by Medicaid between Dec 2021 and Dec 2024, across 35 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 36% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#189 of 561

Median peer was paid$222K

This provider vs. median4.3×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	357	$12K
2022	9,908	$383K
2023	6,281	$262K
2024incomplete	2,127	$294K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	36%	5,035	2,160	$341K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	31%	2,041	1,296	$293K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	12%	577	91	$115K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	10%	5,012	2,140	$97K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	3.9%	2,088	924	$37K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	3.9%	577	91	$37K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	259	158	$9K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	264	229	$8K
80051		<1%	134	126	$1K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	40	36	$1K
82550		<1%	154	146	$966.20
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	181	170	$885.21

23 more codes

80061	Lipid panel	<1%	75	$821.53
84481		<1%	43	$809.26
82310		<1%	164	$778.07
84075		<1%	161	$775.67
82247		<1%	161	$756.94
84545		<1%	166	$713.01
82607		<1%	40	$666.58
84460		<1%	160	$553.79
84450		<1%	161	$537.34
82040		<1%	161	$501.78
82728		<1%	30	$451.30
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	<1%	366	$426.24
84155		<1%	159	$367.44
82962		<1%	161	$348.47
84439		<1%	29	$290.58
82441		<1%	41	$273.47
80053	Comprehensive metabolic panel	<1%	22	$127.40
83036	Hemoglobin; glycosylated (A1C)	<1%	20	$118.30
84100		<1%	17	$89.59
84295		<1%	54	$76.82
84132		<1%	54	$20.48
82435		<1%	12	$14.93
82374		<1%	54	$6.76

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPAMINTUAN, ELINELL (ADMINISTRATOR)